Clinical trial NCT02568904: Alcohol and Innate Immunity
Official title: The Effects of Binge Drinking on Innate Host Defence Mechanisms
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Binge Drinking
Lead sponsor: Medical University of Graz
Sponsor class: OTHER
First posted: 2015-10-06
Enrollment: 46
Sex: ALL
Minimum age (years): 18
Maximum age (years): 99
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: OTHER
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Healthy volunteers selected from a database

Brief summary: Alcohol leads to a leaky gut and translocation of bacterial products. This may lead to inflammation and immune dysfunction as well as the typical hangover symptoms.

Detailed description: Alcohol binge drinking, defined as 5 or more drinks for men and 4 or more drinks for women at one time, is the most frequent form of alcohol consumption worldwide, especially in younger people. This drinking pattern is popular and leads to increased mortality and morbidity. Therefore binge drinking is a major public health issue. The behavioural and neurological consequences of binge drinking are well characterized.

Less is known about the systemic effects on the gut as the first organ in contact with alcohol. Chronic alcohol intake can lead to increased gut permeability, bacterial translocation and alterations in the gut microbiome in animal models. Recently bacterial translocation has been shown in healthy volunteers after a single alcohol binge. On immune cells, acute alcohol intake seems to have dichotomous effects. On the one hand immunosuppressive and anti-inflammatory effects have been described, however, alcohol induced liver injury is driven by pro-inflammatory reactions. These immune effects seem to be driven by endotoxin or other bacterial products via Toll-like receptors that are translocated to the circulation via a defective gut barrier. Immune effects of alcohol have also been linked to hangover symptoms after an alcohol binge.

Furthermore there is evidence that endotoxemia might also contributes to alcohol dependence by promoting prolonged and increased voluntary alcohol intake in mice. On the other hand mutant mice lacking important genes for immune responses exhibit decreased alcohol consumption. This indicates that immune signaling promotes alcohol consumption. Therefore it is tempting to speculate that increased gut permeability leading to increased bacterial translocation after an acute alcohol binge could promote the desire for further alcohol consumption.

The investigators aim to test in this pilot trial whether one alcohol binge damages gut barrier function, increases bacterial translocation and causes innate immune dysfunction. Furthermore the effect of glucose and fructose will be studied too.

Eligibility criteria: Inclusion Criteria:

* Participant is willing and able to give informed consent for participation in the study.
* Age above 18 years
* Willingness to abstain from alcohol 48h prior to the study visits

Exclusion Criteria:

* Alcohol abuse .Alcohol Use Disorders Identification Test ≥ 8 in men or ≥ 7 in women or CAGE test ≥ 2 (both men and women)
* Elevated liver function test
* Any disease or medication that does not allow concomitant consumption of alcohol
* Women: pregnancy and lactation

Primary outcomes:
measure: Endotoxin assessed by percentage of endotoxin positive subjects
timeFrame: 4 hours
Secondary outcomes:
measure: gut permeability (zonulin in stool)
timeFrame: 4 hours
measure: bacterial translocation (bacterial DNA in serum)
timeFrame: 4 hours
measure: oxidative stress (advanced oxidation protein products)
timeFrame: 4 hours
measure: inflammation (neutrophil oxidative burst)
timeFrame: 4 hours
measure: neutrophil phagocytic capacity
timeFrame: 4 hours
measure: gut microbiome composition
timeFrame: 4 hours
measure: fibroblast growth factor 21 (FGF21)
timeFrame: 4 hours
Other outcomes:
Locations:
city: Graz
country: Austria
facility: Department of Internal Medicine, Medical University of Graz
Study officials:
affiliation: Medical University of Graz
name: Vanessa Stadlbauer, MD
role: PRINCIPAL_INVESTIGATOR
References: